Abstract

In this work, six iridium(III) complexes have been designed, synthesized and characterized. The molecular structures of complex 1 ([(pba)2Ir(bpy-2N(CH3)2)]PF6), 2 ([(pba)2Ir(bpy-2NH2)]PF6) and 3 ([(pba)2Ir(bpy-2CH3)]PF6) were determined by single crystal X-ray diffraction. Upon addition of Hcy (homocysteine) to the solution of complex 1, a luminescent variation from orange red to green was observed by the naked eye, corresponding to a large blue shift from 604 nm to 498 nm (~106 nm). While the emission intensity of complex 1 was almost no change after addition of other common amino acids including Cys (cysteine) and GSH (glutathione). The aldehyde group of complex 1 formed a new thiazinane/thiazolidine ring with Hcy/Cys confirmed by 1H NMR and high-resolution mass spectrometry. And the new product 1-Hcy had a higher quantum yield than 1-Cys. Theoretical calculations showed that the HOMO (highest occupied molecular orbital) of 1-Hcy was located on the newly formed six-membered thiazinane ring, which was different from the HOMO of 1-Cys. Compared with the other iridium(III) complexes, we can speculate that the large blue shift and enhancement of the emission intensity of the complex 1 were related to the strong electron donating ability of the modified amino groups on bipyridine ligand. This will provide an idea for the design of ratio-based luminescence probes for Hcy in future.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.